Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older.
- People who have been diagnosed with chronic myeloid leukaemia (CML) in its early, stable phase, and whose condition is suitable for treatment with tablets or capsules taken by mouth.
- People who are newly starting an oral (by mouth) treatment for CML, including those switching from a previous treatment due to it not working well enough or causing side effects — as long as those side effects have cleared up or are very mild (grade 1 or lower) at the time of joining.
- People whose care can be supported by an advanced practice nurse (a specially trained senior nurse).
- People who can understand French and are able to fill in a questionnaire.
Who may not be able to join:
- People who have already been receiving follow-up care from an advanced practice nurse for CML for more than 3 months before the trial starts.
- People switching treatments because of side effects, if those side effects are still more than very mild (above grade 1) at the time of joining.
- People who are already taking part in another interventional clinical trial for CML.
- People who are pregnant.
- People who are under legal protection, have restricted personal liberty, or are in a situation where participation in a research study is not permitted under applicable rules (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christine Tosello, APN, Centre Hospitalier d'Avignon, Service d'Oncologie Médicale-Hématologie Clinique
Phone: (+33)432759392
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluate the role of the advanced practice nurse in early detection of grade I-II adverse events during care and management of Chronic Myeloid Leukemia compared to standard of care (hematologist only).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.